top of page
Vaccinating

Home > Use Cases > Autism

Covid-19

Glutathione and Covid

COVID-19 has been closely linked to oxidative stress and glutathione metabolism. Here’s an overview of how these elements interact:

1. Oxidative Stress in COVID-19

  • Oxidative stress refers to an imbalance between reactive oxygen species (ROS) and the body’s ability to detoxify them or repair the resulting damage. Severe COVID-19 infections can trigger excessive immune responses, leading to inflammation and increased ROS production.

  • The cytokine storm associated with severe cases causes massive oxidative damage, contributing to complications like acute respiratory distress syndrome (ARDS) and multi-organ failure.

2. The Role of Glutathione

  • Glutathione is one of the body’s most important antioxidants. It helps neutralize ROS and maintain a balance in oxidative stress. It’s crucial in:

    • Immune function: Enhancing the activity of T-cells and natural killer (NK) cells.

    • Reducing inflammation: By lowering pro-inflammatory cytokine production.

    • Lung protection: Maintaining the health of lung epithelial cells and reducing mucus production.

  • Low levels of glutathione are associated with:

    • Increased oxidative stress and inflammation.

    • Worse outcomes in COVID-19 patients, including a higher risk of severe symptoms and complications.

3. Glutathione Deficiency and COVID-19 Severity

  • Studies have shown that patients with severe COVID-19 often have reduced levels of glutathione. This deficiency may impair the body’s ability to combat the virus and manage oxidative stress.

  • Risk factors like aging, diabetes, obesity, and cardiovascular disease—which are associated with lower baseline glutathione levels—are also linked to higher COVID-19 severity and mortality.

  • Elderly populations, who are more vulnerable to COVID-19, naturally have lower glutathione levels due to age-related oxidative stress.

4. Potential Therapeutic Implications

  • There’s growing interest in using glutathione supplementation or boosting its levels as part of COVID-19 treatment strategies. Potential options include:

    • N-acetylcysteine (NAC), a precursor to glutathione, which may reduce the severity of symptoms by increasing glutathione levels.

    • Direct glutathione supplements to mitigate oxidative damage, especially in high-risk patients.

    • A focus on supporting the glutathione recycling system, ensuring efficient regeneration of active glutathione.

5. Glutathione Recycling Blood Test

Given the relationship between oxidative stress and COVID-19, testing for glutathione levels and its recycling efficiency could serve as a valuable tool:

  • Early detection of oxidative stress status in patients.

  • Identification of individuals who may be at greater risk for severe COVID-19.

  • Potentially guiding personalized treatment strategies to optimize antioxidant defenses.

If you are a researcher interested in partnering with us or using our glutathione recycling test in a current study or planned future studies, please fill out our form. We would love to discuss it with you and your team.

Mynari

MyNauseaRisk™

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. 

MyNeuropathyRisk™

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Mynari

About

About MYNARI Biomedical

MYNARI Biomedical is a science-driven diagnostic company located in the Philadelphia region. Our purpose is to commercialize novel medical discoveries and deliver life-changing innovations. MYNARI has licensed the exclusive rights to the patented and patent pending MyNauseaRisk™ diagnostic test, and is currently developing the test for commercial use.

bottom of page